[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334096-105":59,"doc-detail-334096-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","treatment-of-secondary-uterine-malignancy-following-radiotherapy-for-cervical-cancer-a-study-based-on-the-seer-database","Treatment of secondary uterine malignancy following radiotherapy for cervical cancer - a study based on the SEER database","","Radiotherapy is a cornerstone treatment for cervical cancer, yet long-term radiation exposure can lead to secondary tumors. This retrospective American-population study evaluates optimal management for radiation-induced secondary uterine malignancy using the SEER database. Definitive cervical cancer cases with a later uterine malignant diagnosis (≥1 year) were analyzed, with Cox regression and Kaplan-Meier survival estimation to identify prognostic factors and compare treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/treatment-of-secondary-uterine-malignancy-following-radiotherapy-for-cervical-cancer-a-study-based-on-the-seer-database/334096/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/treatment-of-secondary-uterine-malignancy-following-radiotherapy-for-cervical-cancer-a-study-based-on-the-seer-database/334096.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study?","Question",{"text":112,"@type":113},"To determine the optimal treatment modality for patients with radiation-induced secondary uterine malignancy after radiotherapy for cervical cancer, using the SEER database.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were eligible patients defined?",{"text":117,"@type":113},"Patients had a definitive pathological diagnosis of cervical cancer and were later diagnosed with a uterine malignant tumor at least 1 year afterward; cases where cervical cancer was not the first tumor or where data were missing were excluded.",{"name":119,"@type":110,"acceptedAnswer":120},"What treatments showed benefit in patients with secondary uterine malignancy after radiotherapy?",{"text":121,"@type":113},"Surgery improved prognosis, and the subgroup receiving surgery plus chemotherapy showed significantly better survival than the other groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334096,1790148018,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Tong et al. BMC Women's Health (2024) 24:475 BMC Women's Health  \n[https://doi.org/10.1186/s12905-024-03331-5](https://doi.org/10.1186/s12905-024-03331-5)  \nRESEARCH Open Access  \nTreatment of secondary uterine malignancy following radiotherapy for cervical cancer: a study based on the SEER database  \nXiaojing Tong 1†, Yunyun Xiao2†, Haozhen Li3, Hang Zhang4 and Jiawen Li 1*  \nAbstract  \nBackground Radiotherapy is one of the main treatments for cervical cancer. Long-term complications of radiation exposure include the emergence of secondary tumors. This is a retrospective study based on an American population. We discuss the optimal treatment modality for patients with radiation-induced secondary uterine malignancy based on the Surveillance, Epidemiology, and End Results database.  \nMethods The study included patients with a definitive pathological diagnosis of cervical cancer who were diagnosed with a uterine malignant tumor ≥ 1 year later. Patients in whom cervical cancer was not the first tumor or patients with missing data were excluded. Univariate and multivariate analyses were performed using the COX regression model to screen independent prognostic factors affecting overall survival. Kaplan-Meier survival curves were analyzed using the R software package.  \nResults We screened 142 patients with a secondary uterine malignancy after cervical cancer treatment, 115 patients with a secondary uterine malignancy after radiotherapy, and 27 patients with a secondary uterine malignancy who did not receive radiotherapy. The average latency period for developing a secondary tumor was 8 years, and 57. 04% of the patients had a second tumor at ≥ 60 years of age. In patients with a secondary uterine malignancy after radiotherapy, surgery improved the prognosis [hazard ratio (HR), 0 . 374; 95% confidence interval (CI), 0 .229–0. 612], whereas radiotherapy and chemotherapy did not reduce the risk of death. In the subgroup analysis, the surgery plus chemotherapy group had a significantly better survival prognosis than the other groups (HR, 0 . 251; 95% CI, 0.122–0. 515) .  \nConclusions The results suggest that the treatment modality in patients with secondary uterine malignancy after radiotherapy for cervical cancer has a significant impact on survival. The survival outcomes of patients receiving surgery combined with chemotherapy are superior to those of patients receiving other treatments.  \nKeywords Radiotherapy, Second uterine malignancy, Treatment, Cervical cancer, SEER database  \n†Xiaojing Tong andYunyun Xiao contributed equally to this work.  \n*Correspondence: Jiawen Li[ljw920502@163.com](ljw920502@163.com)  \n1Department of Gynecology, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, China  \n2Department of Gynecology, Dalian Maternal and Children’s Medical Group, Dalian, China  \n3Department of Stomatology, Medical College of Jinzhou Medical University, Jinzhou, China  \n4Department of Equipment and Materials, The First Hospital of China Medical University, Shenyang, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain per","cbCaiaQP2oTNR4o5","https://ap.wps.com/l/cbCaiaQP2oTNR4o5","pdf",2170598,12,"English","# Background\n## Radiation exposure and secondary malignancies\n# Methods\n## Study population and inclusion criteria\n## Statistical analysis\n# Results\n## Patient screening and latency\n## Treatment effects after radiotherapy\n# Conclusions","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"To determine the optimal treatment modality for patients with radiation-induced secondary uterine malignancy after radiotherapy for cervical cancer, using the SEER database.\"},{\"question\":\"How were eligible patients defined?\",\"answer\":\"Patients had a definitive pathological diagnosis of cervical cancer and were later diagnosed with a uterine malignant tumor at least 1 year afterward; cases where cervical cancer was not the first tumor or where data were missing were excluded.\"},{\"question\":\"What treatments showed benefit in patients with secondary uterine malignancy after radiotherapy?\",\"answer\":\"Surgery improved prognosis, and the subgroup receiving surgery plus chemotherapy showed significantly better survival than the other groups.\"}]","Treatment of secondary uterine malignancy following radiotherapy for cervical cancer - a study based on the SEER database | PDF",1790005240]